Prelude Capital Management, LLC Moderna, Inc. Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $626,802 - $1.07 Million	-5,741 Reduced 57.99%	4,159 $545,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $587,781 - $1.52 Million	8,941 Added 932.33%	9,900 $1.03 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $622,953 - $1.09 Million	-11,464 Reduced 92.28%	959 $68,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $173,052 - $264,361	12,423 New	12,423 $243,000
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $117,011 - $242,051	-8,541 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $49,086 - $80,508	3,397 Added 66.04%	8,541 $174,000
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $69,546 - $96,707	5,144 New	5,144 $79,000

912

239M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.